Meta-analysis of multiple genome-wide association studies (GWAS) is effective for detecting single or multi marker associations with complex traits. We develop a flexible procedure ("STAMP") based on mixture models to perform region based meta-analysis of different phenotypes using data from different GWAS and identify subsets of associated phenotypes. Our model framework helps distinguish true associations from between-study heterogeneity. As a measure of association we compute for each phenotype the posterior probability that the genetic region under investigation is truly associated. Extensive simulations show that STAMP is more powerful than standard approaches for meta analyses when the proportion of truly associated outcomes is ≤ 50%. For other settings, the power of STAMP is similar to that of existing methods. We illustrate our method on two examples, the association of a region on chromosome 9p21 with risk of fourteen cancers, and the associations of expression of quantitative traits loci (eQTLs) from two genetic regions with their cis-SNPs measured in seventeen tissue types using data from The Cancer Genome Atlas (TCGA).
Introduction
Sometimes it is of interest to assess the association of genetic variation within a pre-specified region with different, possibly related, phenotypes, and to quantify heterogeneity of the associations. For example, Li and others (2014) recently studied the associations of single nucleotide polymorphisms (SNPs) in a chromosome 9p21 region with eight cancers that includes interferon genes and several tumor suppressor genes, from eight genome-wide association (GWAS) studies. The authors conducted SNP-level analyses for each cancer and used a subset-based statistical approach (ASSET) (Bhattacharjee and others, 2012) to combine SNP-level p-values across cancers. In another example, Flutre and others (2013) proposed methods to assess single SNP associations between with expression quantitative trait loci (eQTL) expression measured in multiple tissues.
Standard meta-analytic approaches to combine summary information from a single SNP are not powerful when the SNP has an effect in only a subset of phenotypes or in opposite directions for some phenotypes. Multiple methods are available to assess the association of common genetic variants such as GWAS SNPs with risk of multiple phenotypes measured on the same samples (Yang and others, 2016; O'Reilly and others, 2012 ; van der Sluis and others, 2013) but only few methods are available based on summary statistics. ASSET and CPBayes (Majumdar and others, 2017) use summary statistics to identify subsets of studies associated with a particular SNP, but they do not allow one to readily combine information from multiple SNPs in a locus. Information stemming from linkage disequilibrium (LD) is not utilized when analyzing each SNP in a region separately.
Several adaptive gene-based approaches are available to study multiple SNPs simultaneously (Tang and Ferreira, 2012 ; Van der Sluis and others, 2015; Kwak and Pan, 2017) and accommodate heterogeneous SNP effects, or effects that present in some studies. However, these approaches only give global measures of association and do not identify the subset of associated studies.
We therefore propose a new approach to explore genetic heterogeneity of associations for a genomic region with different phenotypes and to identify a subset of phenotypes that are associated with that region. First, for each phenotype separately, we combine the SNP specific association estimates using an aggregated level test statistic. We then assume that the test statistics arise from a mixture distribution with two components, one under the null model of no association of the study specific phenotype with the genetic region, and one distribution assuming that there is an association. We use a hierarchical model to describe SNP effects (Section 2) that can accommodate varying levels of between-phenotype heterogeneity. We then test if the mixture distribution provides a better fit to the region specific test statistics from all studies than a single component density, estimate the parameters of the mixture and compute posterior probabilities that a particular phenotype is associated with the genomic region (Section 3). As an illustration, we analyzed the association of the 9p21 region (using GWAS SNPs) with various cancers, and the genetic associations of eQTLs from two genetic regions measured in seventeen different tissue types (Section 4).
We study our method in simulations (Section 5) and compare its power to existing meta analytic approach, before closing with a discussion (Section 6).
2 Data and models
Association models
We now describe the model assumed to govern the association between a particular phenotype Y s and genotypes X s = (X s1 , . . . , X sps ) for p s SNPs measured in a genomic region, where X si = 0, 1, or 2 denotes the number of minor alleles at locus i, i = 1, . . . , p s . Here we allow for different numbers of SNPs measured in a genomic region for different phenotypes. We consider the generalized linear model (GLM) setting (see e.g. McCullagh and Nelder, 1989) , and assume that the conditional expectation of Y s given X s is
where h is a known function and (γ s0 , γ s ) a vector of p + 1 association parameters for the SNP.
If the k-th SNP is not associated with Y s , γ sk = 0. Additional covariates Z s = (Z s1 , . . . , Z sq ) can
We assume that F is a probability density or mass function from the exponential family (McCullagh and Nelder, 1989) .
Properties of estimates obtained from marginal SNP models
In GWAS studies the estimateβ sj for the association of the jth SNP with outcome Y s is typically obtained by maximizing a marginal likelihood that only includes the genotype X sj for the jth SNP in the specification of the mean function instead of the whole vector X s ,
where h denotes the same function as in (1). If additional covariates Z s are available, (2) can be
We use the subscript G to denote the misspecified marginal mean probability model that uses only individual SNP genotypes. We show in the Appendix 1.A that, conditional on γ s , the estimateβ sj based on (2) converges to β sj that satisfies the equation
where γ si is the true associate parameter for SNP i in (1), when h is the identity link function h or the logistic link, under both, prospective and retrospective sampling, i.e. for case-control data assuming rare disease. As can be seen directly from (3), when there is no association, i.e. γ si = 0 for all SNPs i = 1, ..., p s , then also β si = 0 for all i = 1, ..., p s , and when the SNPs are uncorrelated, then β si = γ si . Using the matrix Ω s defined element-wise as
and conditional on the vector of true effects γ s , the estimatesβ s = (β s1 , . . . ,β sps ) from the marginal model (2) have the following limiting distribution
where Σ s = Cov(β s |γ s ), which is typically not known for the marginal estimates. For small effects γ s , following Hu and others (2013) ,
where Υ s = Cor(X s ) is the correlation matrix between the p SNPs that is assumed to be known and D s = diag(σ s1 , . . . , σ sps ) is a diagonal matrix of standard error estimates σ sj ofβ sj , j = 1, ..., p s .
Xs
Xs . Yang and others (2012) derived similar results to (3) using a least squares approach for the linear model and extended it to casecontrol data using a liability threshold model.
Hierarchical model for SNP effects
We assume that the study and phenotype specific association parameters γ s in (1) arise from a multivariate normal distribution,
where µ s = (µ s1 , . . . , µ sps ) and τ s = (τ s1 , . . . , τ sps ) denote the phenotype specific association parameters and Λ s = diag(τ s ) is a diagonal matrix. The components µ sj and τ sj , j = 1, . . . , p s , of µ s and τ s , are assumed to be independent random draws from two possible super-populations, one for associated phenotypes and one for phenotypes that exhibit no associations with the region (Figure 1 ). We do not assume any specific distributions for the super-populations, we only describe them through their moments.
We distinguish between phenotype specific mean SNP effects µ s and study specific effects γ s as different studies for the same genotype could have different "true" associations, e.g. due to differences in unmeasured confounders. If there are multiple studies for each phenotype, then (µ s , τ s ) can be estimated from available data. Otherwise, only the super-population parameters in the top hierarchical layer can be estimated.
Super-population distribution for SNP effects, H(µ, τ ) with E(µ 4 ) < ∞ and E(τ 2 ) < ∞ Phenotype specific parameters µ sj and τ sj , j = 1, . . . , p s for the p s SNPs are iid draws from H, resulting in
Study specific parameters for phenotype s:
Study specific marginal estimateŝ
Figure 1: Hierarchical model set-up for study specific estimates for particular phenotype s
Based on equations (5) and (7), the conditional distribution ofβ s iŝ
where Σ s is given in (6). To recover the true association parameters µ s and Λ s , we rotate the estimates, to obtainβ * (Han and Eskin, 2011; Lee and others, 2013; Tang and Lin, 2014; Shi and Lee, 2016) , µ s ≡ 0, and τ s ≡ 0 for all SNPs in a region, and thus γ sj ≡ 0, j = 1, ..., p s , without any variation. Thus the first three levels in the hierarchical model in Figure 1 can be collapsed, and it
Several super-population models are appropriate when m w 0 is used for those Y s for which there are associated SNPs in the genetic region. The first is to assume that E(µ sj ) = 0 and V ar(µ sj ) + V ar(τ sj ) = 0. This setup has been used previously for variance component testing in random effect models (e.g. Lin, 1997) and for het-SKAT (Lee and others, 2013) . Alternatively, one could let E(µ sj ) = 0 and V ar(µ sj ) + V ar(τ sj ) = 0, which is assumed in fixed effect meta analysis (Cochran, 1954) . Han and Eskin (2011); Tang and Lin (2014) for phenotypes with associations in the region, that has been used in the context of meta-analysis (e.g. Han and Eskin, 2011; Tang and Lin, 2014; Shi and Lee, 2016) , assumes that E(µ sj ) = 0 or V ar(µ sj ) = 0. Here, we require the availability of a 'negative' control study, i.e. a phenotype Y s that is known not to be associated with the genetic region, to be able to distinguish between sources of variation in the genetic effects, i.e. between V ar(µ sj ) and E(τ sj ).
To summarize, the distributions of the rotated estimates of effect sizes in (9) simplify tô
under the two models of no genetic associations.
3 Assessing the association of a genetic region with multiple phenotypes
We assume now that we have one study for each phenotype Y s . For each phenotype Y s we combine the linearly transformed values Σ * −1 sβ * s using a linear or quadratic statistic T s , which are asymptotically equivalent to variance component tests to assess high dimensional alternatives (Derkach and others, 2014; Tang and Lin, 2014; Lee and others, 2012) Linear tests have good power if a large proportion of SNPs in the region under consideration are associated and have effects in the same direction, while quadratic test statistics are robust to different signs of effect estimates and are more powerful when the proportion of associated SNPs in the region is small (e.g. Derkach and others, 2014) . Under heterogeneity of associations of phenotypes Y s , s = 1, . . . , S, we assume that T s arises from a mixture model that we present next.
Mixture model
If only a proportion of the phenotypes Y s , s = 1, . . . , S, are associated with the genetic region under investigation, we assume test statistics T s arise from a mixture distribution, due to two super populations giving rise to the observed estimates,
In (11), ϕ 0 denotes the density of T s under the null model of no association of that particular genetic region with Y s , and ϕ 1 is the density when the region is associated with the phenotype.
The mixing proportion π can be interpreted as the prior probability of a phenotype having genetic associations. Functional information can be incorporated into π, e.g. by using a covariate Z s that captures biologically relevant data through
For both, our linear and quadratic summary statistics T s , ϕ 0 and ϕ 1 can be approximated by normal densities. We discuss the parameterization of E i (T s ) and V ar i (T s ), i = 0, 1, and the estimation of model (11) in detail in Sections 3.2 and 3.3, respectively and summarize it in Table 1 .
The basic steps for assessing heterogeneity of associations for phenotypes Y s , s = 1, . . . , S, and for identifying the subset of phenotypes associated with a genomic region are as follows. 
Use a likelihood ratio test (LRT) to test if the statistics
the probability that the region is associated with a particular phenotype Y s , i.e. the posterior
.
3. Ifp s > p * for some prespecified threshold, e.g. p * = 0.5, then phenotype Y s is considered to be associated with the region.
A linear summary test statistic, T L s
We first propose and study a linear test statistic to combine transformed SNP effects,
Asβ * sj is asymptotically normally distributed, T L s conditional on µ s and Λ s is normally distributed with moments
The unconditional mean and variance of T
The numerator of the variance of T L under the strong null model is 1 Σ * −1 s 1 and under the weak (14) do not simplify further. For the LRT based on the weak null model we estimate four parameters under the alternative model and one under the null model (see Table 1 ).
A quadratic summary test statistic, T Q s
The linear test statistic T L s in Section 3.2 has the disadvantage that it is sensitive to the directions of the associations, i.e. the signs of the β * si , i = 1, . . . , p s , and is not powerful when signal comes from only a few SNPs. To overcome these limitations we also combine the p s SNP estimates for phenotype s using a quadratic form, (Derkach and others, 2014; Tang and Lin, 2014) . Here, we let W s = I, where I denotes identity matrix. This choice may improve power because it assigns bigger weights to the largest principal components of Cov(X), which are likely to explain a large proportion of the phenotypic variation. For small γ i , T Q s is asymptotically equivalent to the C-alpha test for rare variants under local alternatives (Neale and others, 2011) . Other choices of W s based on MAFs were proposed in Wu and others (2011) and Basu and Pan (2011) in the context of rare variant analysis.
Based on the conditional moments given in Appendix 1.B, the unconditional moments are
where e ψ = V ar(µ) + E(τ ) quantifies the variability in genetics effects due to within locus and between study heterogeneity and e ζ = 3V
is used to capture the higher order moments of the super-population. Letting
In summary, (16) and (17) depend on the following moments of the distribution of µ s and τ s :
), E(τ ) and V ar(τ ) (see Table 1 ). The moments of T Q s for a general matrix W s are given in the Appendix 1.B. Under the strong null model, (16) and (17) simplify to
, and under the weak null model to
The identifiability of the parameters in the first two moments of T Q s under either null model can be seen immediately. Here, we thus discuss identifiability of ζ, ψ, E(µ) and E(µ 3 c ) from (16) and (17) (e.g. the SNPs are independent), we cannot distinguish between effects of E(µ 2 ) and E(τ ). This special case is further discussed in Appendix 1.C. We do not generate T Q s directly from a normal distribution, because when p s , the number of SNPs is small, or LD is high in the region, the normal approximation may not be appropriate.
Testing for heterogeneity of associations among studies
Instead, we generate the estimates of the effect sizes as functions of τ as follows.
We estimate E(τ ) and E(τ 2 ) by solving two unbiased estimation equations under the restriction that the estimates cannot be negative, 
to obtainV (τ ) = max 0,Ê(τ 2 ) −Ê(τ ) 2 . We then draw the elements of the diagonal matrix Λ s (r)
from an inverse-gamma distribution with the first two moments equal toÊ ( 
Data examples
We illustrate our method on two data examples, one that uses binary phenotypes and one based on continuous Y s .
Association of a chromosome 9p21 region with multiple cancers
We used data from GWAS studies in dbGaP to assess the association of a region on chromosome 9p21 with fourteen different cancers (see Supplemental Table S1 ). To assess the impact of LD on the approach, we applied LD pruning of the SNPs with LD thresholds (e.g. pairwise LD) 0.25, 0.5 and 0.75. As we had access to individual level data from all studies, we first estimated the log-odds ratioβ sj and standard error for each SNP j for each cancer s separately, from logistic regression models adjusted for gender, age, study and 10 principle component scores to control for population stratification. SNPs were coded as 0, 1,or 2 minor alleles in these models. Additionally we computed phenotype-specific estimatesΩ s in (4). We then computed p-values for T L and T 
where V ar 0 (T L s ) is calculated under the strong null model and
which is Het-MetaSKAT (Tang and Lin, 2014; Lee and others, 2013) with weights set to 1. To test under the weak null model, we used pancreatic cancer as a negative control.
Results from the various methods are presented in Table 2 For the LD threshold 0.5, the parameters in the mixture model wereπ = 0.2, E(µ) = 0.0018, and E(µ 3 c ) = −0.0005. The small value of E(µ) indicates that signal is likely sparse in the region. We observed extremely low estimates of the heterogeneity parameters eψ = 1.6 × 10 −3 and eζ = 1.5 × 10 −8 because only two cancers, esophagus and stomach had a strong association with the region. The same results were observed for SNPs selected using the LD threshold of 0.25 and 0.75 (see Supplemental Tables S4 and S5) . Results for stomach, esophagus cancers and glioma were previously reported to be associated with the region (Li and others, 2014 ). Table S6 ).
Associations of two genetic regions with expression of quantitative trait loci (eQTL) data from multiple tissues
To illustrate our method for continuous Y s , we used genotype and total gene expression data based on RNA sequencing for 17 tumor tissues from The Cancer Genome Atlas (TCGA) project. Details on data processing are described in Supplementary Materials of Heller and others (2017). Here we focused on eQTL data from two genes, CTSW and LARS2, and the association with SNPs in their cis region (i.e. less than 1000,000 base pairs from the target gene).
We first estimated coefficientsβ sj and standard errors for each SNP j for each tumor tissue s from linear regression models, adjusted for sex, age and the top five principle component scores, and obtained phenotype-specific estimatesΩ s for genotype correlations in (4). We then computed standard meta analytic tests, T Results for the CTSW gene are presented in Table 3 for the LD threshold 0.5 and in Supplemental Table S7 for LGG, LUAD, LUSC ,OV, PRAD, and SKCM) tissues, and suggestive evidence was provided for two tissues, UCEC and LIHC (with posterior probabilitiesp s of 0.61 and 0.45, respectively). We note that three tissues (KIRP, PRAD and SKCM) had individual study p-values > 0.003, but posterior probabilitiesp s > 0.80 (Table 3) . Two of these tissues had small sample sizes, highlighting that small studies sometimes borrow more information from the overall set of studies. We also note that the p-value from the KIRC tissue was similar to that for the PRAD tissue (both approximately equal to 0.04); however, the posterior probability estimate for this tissue wasp s ≈ 0. Large values of these parameters indicate that a single density with heavy tails is the best fit to the data. Therefore, our approach may have lower specificity when the proportion of associated studies and estimated effects are heterogeneous as indicated by a large posterior probability for the PAAD tissue, which had a marginal p-value of 0.41.
For this example, we did not test under the weak null model as we did not have knowledge about a negative control study. 
Setup
We assessed the type 1 error and the power of the mixture method for both binary and continuous outcomes, Y s . To generate realistic patterns of LD, we used genotypes of common SNPs (MAF≥ 5%) on chromosome 6 observed in the 4631 controls from the glioma study (Rajaraman and others, 2012 ) also used in Section 4.1. We applied LD pruning to ensure that the maximal pairwise LD between SNPs was no larger than 0.5. For each setting we generated S = 20 studies, of which S C = 0, 1, 5, 10 and 15 studies had SNPs associated with Y s . We investigated two LD patterns.
For the "high LD pattern" setting we used genotypes for 210 common SNPs in the region from 29600054bp to 31399945bp on chromosome 6 (HLA I class region). For the "low LD pattern", we selected p = 210 SNPs in the region from 110391bp to 1525603b on chromosome 6 with pairwise LD smaller than 0.5. We also studied the impact of sample size of the studies with no signal on power.
For binary Y s , the sample size for studies with truly associated SNPs was N For studies under the strong null model, we generated N = 5000 phenotypes Y si from N (0, 1) and for binary Y s , we randomly assigned 2500 cases and 2500 controls to 5000 genotypes. For the S c studies with truly associated SNPs, we randomly selected p C = 11 of the p = 210 SNPs and generated γ sj for j = j 1 , ..., j 11 in model (1) from generated N (µ sj , τ sj ), where
and τ sj ∼ T N {E(τ ), (E(τ )/2) 2 } where T N denotes a normal distribution truncated at 0. Continuous phenotypes were generated from Y is = γ s X is +e si , where e si ∼ N (0, 1). For simulations based on case control data, we generated Y s ∼ Bernoulli(q s ), where q s = exp(γ 0 + γ s X is )/ {1 + exp(γ 0 + γ s X is )} with γ 0 = log(0.01/0.99) for a large cohort and then sampled cases and controls.
Under the weak null model for null SNPs, we generated γ sj from γ sj ∼ N (0, τ sj ) and τ sj ∼ T N {E(τ ), (E(τ )/2) 2 } for s = 1, ..., 20. For the S C studies with p C = 11 randomly selected truly associated SNPs, we generated γ j for j = j 1 , ..., j 11 using the hierarchical structure in Figure 1 . 
Simulation results

Type 1 error for testing for heterogeneity of associations
The empirical type 1 error rates for our T M ix when LD was low, the empirical type 1 error was slightly conservative for both internal and external estimates of Ω s . However, when LD was high, the empirical type 1 error estimates were more conservative for both null models for external estimates of Ω s that do not capture LD patterns as accurately as internally estimated Ω s . Overall our empirical results confirm that the type 1 error is controlled when p s is large.
Power to test under the strong null model
Here , Number of causal studies 1; τ≡0
Ε(µ)
Tests: (Figure 3) , because ϕ 0 has mean equal to 0 under the null model. Lastly, the power for testing under the weak null model was much higher when the null studies had larger sample sizes, because they provide more information on the true amount of heterogeneity captured by τ .
Discussion
We proposed a novel approach based on a mixture model to assess the heterogeneity of associations of genetic variation in a pre-specified region with different phenotypes, and to identify the subset of phenotypes associated with the region. Our simulations and a data example using eQTL data Number of causal studies 1; E(τ)=0.001
Ε(µ)
Tests: 
Tests: show that when the proportion of associated phenotypes is less than 50%, combining region specific estimates using a quadratic test statistic under the mixture model assumption had much better power to identify truly associated outcomes than standard meta analytic approaches. However, when the proportion of associated outcomes was high, standard meta analytic methods were more powerful than our approach. Similar conclusions were previously reached in the context of testing rare variants, where using linear tests with data driven weights worked well when the proportion of variants with signal was low, but a simple sum test had better power when the proportion was high (Derkach and others, 2014) .
There are many tests for associations between a genetic region and a single phenotype for common (e.g. Zaykin and others, 2002; Van der Sluis and others, 2015) and rare SNPs (e.g. Neale and others, 2011; Lee and others, 2012) . Aggregated level methods for common variants for testing gene-and pathway level associations typically are based on p-values (Van der Sluis and others, 2015).
Few methods exist to assess cross-phenotype associations using summary statistics. Bhattacharjee and others (2012) extended fixed effects meta analysis for a single SNP by allowing some subsets of outcomes to have no associations. Our method expands this work in two ways. First, we aggregate association estimates from multiple SNPs measured in a region, and thus utilize information stemming from LD. We also quantify heterogeneity between associations for different phenotypes.
Another advantage of our approach is that it allows one to incorporate prior or external information on the likelihood that a phenotype exhibits associations with a region via the mixing proportion, which can improve identification of associated outcomes. Our framework also extends a recently proposed Bayesian method (CPBayes) for testing the association between a single SNP and multiple phenotypes (Majumdar and others, 2017) . CPBayes imposes a spike and slab prior on the genetic SNP effect and uses a mixture of two normal distributions to represent the SNP effect under the null and alternative models. When a single SNP is analyzed, our mixture set up corresponds to that of CPBayes. However, we additionally estimate the amount of heterogeneity between outcome specific associations, captured by the parameter τ , directly from the data, while in Majumdar and others (2017) it is pre-specified. Mis-specifying the amount of heterogeneity will lower power, sensitivity and specificity of the procedure in Majumdar and others (2017).
Our approach also differs from other recently proposed methods for gene-based testing that require phenotypes to be measured on the same individuals to estimate between phenotype correlations (Van der Sluis and others, 2015; Tang and Ferreira, 2012; Kwak and Pan, 2017) . For cancer outcomes one could simply assume outcomes are uncorrelated, as it is exceedingly unlikely to be diagnosed with two primary cancers and apply these methods to the summary statistics from multiple studies to test whether there is at least one study that shows associations. However, these methods cannot identify which particular outcomes are associated with the SNPs in a gene/region.
Our work extends beyond testing the presence of any association between SNPs in a region for multiple outcomes. Using the weak null model, we also assess if associations are due to common signal or due to heterogeneity. A limitation is that to test under the weak null model, we require availability of a study without association. This control phenotype study helps distinguish between-study heterogeneity from true underlying associations. Another limitation of our method is that if study specific estimates of Ω s are not available, one needs to use publicly available genetic data such as 1000 Genomes Project Consortium (2010) to estimate Ω s , which results in somewhat including lower power.
Several problems remain to be addressed in future work, handling shared controls between studies and more efficient permutation approaches to compute p-values for our model.
Software
Software in the form of R code, together with a sample input data set and complete documentation is available at https://github.com/derkand/STAMP.
